GLG Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$970K Sell
9,290
-6,321
-40% -$713K 0.05% 296
2017
Q3
$2.28M Buy
15,611
+1,611
+12% +$219K 0.12% 186
2017
Q2
$1.82M Hold
14,000
0.1% 210
2017
Q1
$1.74M Hold
14,000
0.08% 240
2016
Q4
$1.62M Sell
14,000
-7,500
-35% -$835K 0.06% 245
2016
Q3
$2.25M Sell
21,500
-4,850
-18% -$525K 0.07% 280
2016
Q2
$2.6M Hold
26,350
0.08% 260
2016
Q1
$2.64M Sell
26,350
-49,750
-65% -$5.12M 0.07% 242
2015
Q4
$9.11M Buy
76,100
+36,865
+94% +$4.27M 0.29% 97
2015
Q3
$4.24M Buy
39,235
+8,901
+29% +$1.1M 0.11% 200
2015
Q2
$3.51M Sell
30,334
-24,583
-45% -$2.81M 0.09% 227
2015
Q1
$6.33M Buy
54,917
+11,122
+25% +$1.33M 0.21% 137
2014
Q4
$4.9M Sell
43,795
-29,552
-40% -$3.12M 0.14% 163
2014
Q3
$6.95M Buy
73,347
+28,799
+65% +$2.6M 0.16% 176
2014
Q2
$3.83M Buy
+44,548
New +$3.39M 0.09% 207

Other funds holding CELG

GLG Partners's CELG Position: Q4 2017 in Review

GLG Partners reduced its Celgene Corp (CELG) stake by 40% in Q4 2017, selling an estimated $713K and leaving 9,290 shares worth $970K. The position accounts for 0.05% of the portfolio, ranked #296.

GLG Partners first reported a position in CELG in Q2 2014 and has held it in 15 quarters since. The position peaked at $9.11M in Q4 2015. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • GLG Partners held 9,290 shares of Celgene Corp worth $970K as of Q4 2017.
  • GLG Partners sold 6,321 Celgene Corp shares in Q4 2017, an estimated $713K.
  • Celgene Corp made up 0.05% of GLG Partners's portfolio in Q4 2017, its #296 holding.
  • GLG Partners first reported a position in Celgene Corp in Q2 2014 and has held it in 15 quarters since.
  • GLG Partners's Celgene Corp position peaked at $9.11M in Q4 2015.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.